Sulfadicramide
 | |
| Names | |
|---|---|
| Preferred IUPAC name N-(4-Aminobenzene-1-sulfonyl)-3-methylbut-2-enamide | |
| Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
| ChEMBL |
|
| ECHA InfoCard | 100.003.727  |
| KEGG |
|
PubChem CID |
|
| UNII |
|
CompTox Dashboard (EPA) |
|
| |
| Properties | |
Chemical formula | C11H14N2O3S |
| Molar mass | 254.30546 g/mol |
| Pharmacology | |
| S01AB03 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).  N verify (what is  Y N ?) Infobox references | |
Chemical compound
Sulfadicramide (marketed as Irgamid) is an anti-infective.[1]
References
- ^ Grześkowiak, E.; Partyka, D.; Simon, M.; Zgrabczyńska, M.; Wiśniewska, A. (2001). "Technology and physico-chemical evaluation of solid ocular inserts containing sulfadicramide and hyaluronic acid". Acta Poloniae Pharmaceutica. 58 (6): 453–458. PMID 12197618.
- v
- t
- e
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
| DHFR inhibitor | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sulfonamides (DHPS inhibitor) |
| ||||||||
| Combinations |
| ||||||||
| Other DHPS inhibitors |
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
| 1st generation | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fluoroquinolones |
| ||||||||
| Newer non-fluorinated | |||||||||
| Related (DG) |
inhibitors
| Nitroimidazole derivatives | |
|---|---|
| Nitrofuran derivatives |
| Rifamycins/ RNA polymerase | |
|---|---|
| Lipiarmycins |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
